Serodus has been invited to attend the 34 Annual J.P. Morgan Healthcare Conference January 11-14, 2016.

Serodus is a drug development company, focusing on new therapeutic products for the treatment of cardiovascular and metabolic diseases with large unmet clinical needs. Part of the company's business model is to seek collaborations with the pharma industry. The J.P. Morgan Healthcare Conference will provide the opportunity to present the company to both the pharma industry and investors.

For request about a meeting or our availability please contact:

Tore Kvam

CFO, Serodus ASA

Mobile: +47 959 34 199

e-mail: tore.kvam@serodus.com

Serodus ASA issued this content on 2015-12-17 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2015-12-17 08:37:05 UTC

Original Document: http://www.serodus.com/News/2015/Serodus-at-the-34th-J.P.-Morgan-Healthcare-Conference